Join
Live feed
·
PRReleasevia Quantisnow
Bicycle Therapeutics plc logo

Bicycle Therapeutics to Present End of Dose Escalation Data from Ongoing Phase I/II Study of BT8009 at the 2023 ASCO Genitourinary (GU) Cancers Symposium

ByQuantisnow·Wall Street's wire, on your screen.
BCYC· Bicycle Therapeutics plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BCYC (Bicycle Therapeutics plc) and more on Quantisnow.